TY  - GEN
AU  - Fan,Rong
AU  - Sun,Jian
AU  - Yuan,Quan
AU  - Xie,Qing
AU  - Bai,Xuefan
AU  - Ning,Qin
AU  - Cheng,Jun
AU  - Yu,Yanyan
AU  - Niu,Junqi
AU  - Shi,Guangfeng
AU  - Wang,Hao
AU  - Tan,Deming
AU  - Wan,Mobin
AU  - Chen,Shijun
AU  - Xu,Min
AU  - Chen,Xinyue
AU  - Tang,Hong
AU  - Sheng,Jifang
AU  - Lu,Fengmin
AU  - Jia,Jidong
AU  - Zhuang,Hui
AU  - Xia,Ningshao
AU  - Hou,Jinlin
TI  - Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues
SN  - 1468-3288
PY  - 2016///0509
KW  - Adult
KW  - Cohort Studies
KW  - Female
KW  - Hepatitis B Antibodies
KW  - analysis
KW  - Hepatitis B e Antigens
KW  - immunology
KW  - Hepatitis B, Chronic
KW  - Humans
KW  - Interferon-alpha
KW  - therapeutic use
KW  - Male
KW  - Nucleosides
KW  - Polyethylene Glycols
KW  - Recombinant Proteins
KW  - Retrospective Studies
KW  - Sensitivity and Specificity
KW  - Seroconversion
N1  - Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1136/gutjnl-2014-308546
ER  -